Hanmi Pharm. Co., Ltd. (128940.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

18.0x

Market Cap

KRW 6.62T

MomentumView details →

1D Return

−2.85%

YTD Return

+4.76%

RSI (14)

56.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

18.0x

Market Cap

KRW 6.62T

RSI (14)

56.0

MomentumView details →

1D Return

−2.85%

YTD Return

+4.76%

ProfitabilityView details →

Gross Margin

59.59%

Net Margin

13.11%

EBITDA Margin

22.94%

ROE (TTM)

15.46%

ROA (TTM)

9.30%

Asset Turnover

0.73x

GrowthView details →

Revenue YoY

+12.93%

EPS YoY

+118.74%

FCF YoY

+134.21%

Revenue CAGR 3Y

+5.14%

EPS CAGR 3Y

+27.07%

EBITDA YoY

+44.11%

EarningsView details →

EPS (Actual)

KRW 6,503.01

EPS Surprise

60.09%

Beats (12Q)

1/12

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

60.09%

Rev Surprise

8.46%

Capital & dividendView details →

Debt/Equity

0.30x

Current Ratio

1.82x

Quick Ratio

1.17x

Div Yield

0.43%

Div Rate

KRW 2,000.00

Div Growth 1Y

+700.00%

Financials snapshotView financials →

Revenue (TTM)

1.66T

Net Income (TTM)

217.04B

Op. CF (TTM)

269.97B

Next earningsOct 29, 2026 →

Latest newsMore news →

No recent news for 128940.KS.

Similar companies

Yuhan Corporation000100.KS Yuhan Corporation000105.KS Hanall Biopharma Co.,Ltd009420.KS Celltrion Pharm, Inc.068760.KQ Daewoong pharmaceutical Co.,Ltd069620.KS JW Pharmaceutical Corporation001067.KS Find similar companies →

Latest newsMore news →

No recent news for 128940.KS.